For our friends in Europe, we kindly suggest the following sessions at #DIA2013 in Boston, MA.

For our friends in Europe, we kindly suggest the following sessions at this year's annual meeting in Boston, MA.

Challenges for Stable Supply of Drugs and International Cooperation

What is the current drug supply situation in US, EU and Japan?

European Town Hall: Implementation of New Safety Legislation and Other Hot Topics

European Town Hall: Implementation of New Safety Legislation ~ #CHMP #CMDh
Cooperation Among Regulators: Impact on Stakeholders             
What is the impact of cooperation among drug regulators on organizations on stakeholders?

US and EU Regulatory Update of Clinical Trial Disclosure                

What are patients’ expectations about clinical trials and registries/results databases?

Risk Management in the US, EU and Japan: The Challenges of Diversity

What are differences in legislation for risk management between the US, EU and Japan?

Learnings from Safety Communications Across the Industry: Patients and EMA, REMS, and FDA, Physicians, and Medical Information Groups

#MedComms symposium ~ How do FDA MedWatch, EMA, and REMS affect your work?

 

Sign up for DIA's Global SmartBrief eNews for the latest in drug development innovations worldwide.